Charles Schwab Investment Management Inc Journey Medical Corp Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Journey Medical Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 30,451 shares of DERM stock, worth $223,814. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,451Holding current value
$223,814% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
62Shares Held
7MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$13.6 Million0.8% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$8.47 Million0.04% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.36 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA565KShares$4.15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA262KShares$1.93 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $85.2M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...